URL Pharma, a specialty pharma company, has acquired the manufacturing assets of PharmPro, a division of Fluid Air, Inc. The acquisition expands the capacity and capabilities of URL Pharma’s product development and manufacturing operations.

The 19,000 sq. ft. facility, located in Aurora, IL, includes fluid bed technology, enabling water and solvent coating processes critical to the development and manufacture of a wide array of modified release products. The acquisition also includes DuraGran, a proprietary platform technology that enables the efficient production of uniform, small granules in the development and manufacture of modified release dosage forms. The site is FDA inspected and DEA licensed.

“This acquisition brings fluid bed technology in-house, enabling us to develop and manufacture a broad range of products for our pharmaceutical technology and brand pipelines,” commented Richard H. Roberts, M.D., Ph.D., URL’s president and chief executive officer. “As part of this transaction, 17 former Fluid-Air employees, many with critical engineering expertise, will join URL Pharma and help integrate the new technology into our product development and manufacturing operations.”

Sign up today for Contracting &Outsourcing 2009!